Clinical and steroid metabolic studies in four siblings with congenital virilizing adrenal hyperplasia.
D015068:17-Ketosteroids / Q000652:urine*; D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000503:physiopathology*; D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000494:pharmacology; D000328:Adult; D000450:Aldosterone / Q000652:urine*; D000804:Angiotensin II / Q000494:pharmacology; D002648:Child; D003907:Dexamethasone / Q000494:pharmacology; D004967:Estrogens / Q000097:blood*; D005260:Female; D006062:Gonadotropins / Q000652:urine*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D011276:Pregnanediol / Q000652:urine*; D011279:Pregnanetriol / Q000652:urine*; D012964:Sodium / Q000378:metabolism; D013739:Testosterone / Q000097:blood*; D014882:Water-Electrolyte Balance
D015068:17-Ketosteroids; D004967:Estrogens; D006062:Gonadotropins; D000804:Angiotensin II; D011279:Pregnanetriol; D013739:Testosterone; D000450:Aldosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D011276:Pregnanediol; D006854:Hydrocortisone; D008797:Metyrapone